Diatech Pharmacogenetics will participate as an exhibitor at the 38th European Congress of Pathology (ECP) in Stockholm, one of the world’s leading events for pathology and molecular diagnostics. The congress brings together pathologists, researchers, and healthcare professionals from across the globe to discuss the latest scientific advances and innovations shaping the future of precision medicine.
Diatech’s participation reflects its ongoing commitment to advancing molecular diagnostics through innovative solutions that support faster, more accurate, and more accessible cancer testing. Throughout the congress, the company will showcase its comprehensive portfolio of molecular diagnostic technologies and engage with the international pathology community to foster collaboration, exchange expertise, and contribute to the continued evolution of precision oncology.
By attending the event we aim to:
- exchange knowledge with the international pathology community
- Strengthen partnerships with distributors, laboratories, and healthcare professionals
- Exchange knowledge with the international pathology community